Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - TransCode Therapeutics, Inc. | StockGist | StockGist

Companies
RNAZ
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings RNAZSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

TransCode Therapeutics, Inc.

Filed Jan 7, 2026

Accepted Jan 6, 2026, 7:00 PM ET

CIK 0001829635

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Transcode Therapeutics, Inc.

Person Type

CO

CUSIP: 89357L501

Amendment History

3 filings

SCHEDULE 13G
Original
Aug 14, 20250000769993-25-000533
SCHEDULE 13G/A
Amendment 1
Aug 14, 20250000950170-25-109220
SCHEDULE 13G/A
Amendment 2
Latest
Viewing
Jan 7, 20260001535610-26-000003

Recent Filings

TransCode Therapeutics, Inc.1 months ago

TransCode Therapeutics, Inc.1 months ago

TransCode Therapeutics, Inc.1 months ago

TransCode Therapeutics, Inc.2 months ago

TransCode Therapeutics, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice